Developer docs
API playgroundTry for free, no card

Search company profiles

Impetus Grants

Full company profile

uuid0003tsx

Namestring
Impetus Grants
Legal namestring
Norn Group Inc.
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Impetus Grants is a 501(c)(3) nonprofit grant-making program operated under Norn Group Inc., founded in 2021 and based in San Francisco. It deploys philanthropic donations as research grants of up to $500,000 per project to academic and independent scientists working on high-risk, high-reward questions in aging biology and longevity science. The organization positions itself as filling the gap between government funders (which it characterizes as too slow and risk-averse for speculative ideas) and venture-backed company formation (which it characterizes as too early-stage for some avenues of investigation), with a stated 3-week application-to-decision turnaround and approximately 1% overhead.

Its core offering is a recurring grant cycle, currently anchored by three completed rounds (145 projects, $34M+ cumulatively deployed, 237+ acknowledging publications including in Science, Cell, and Nature) plus an active fourth round, the AI-Enabling Datasets focused initiative, which funds open-source, AI-ready datasets covering organ-level and longitudinal measurements. Funded research areas span senolytic CAR-T cell therapy, single-cell aging atlases, rapamycin clinical trials (ERAP, VIBRANT), and aging biomarker validation. Pricing to recipients is effectively a standardized grant award; the organization earns no revenue in the commercial sense and is funded entirely by donations from named philanthropists and foundations, including a 2023 $10M joint commitment from Hevolution Foundation and Rosenkranz Foundation and a $15M AI-Enabling Datasets round with anchor matching from Robert Rosenkranz.

Short descriptiontext

Impetus Grants is a 501(c)(3) nonprofit program under Norn Group that provides up to $500,000 within 3 weeks to scientists pursuing high-risk, high-reward research in aging biology and longevity science.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
longevity research funding, aging biology grants, scientific research grants, healthspan research, nonprofit grantmaking
Industry2 codes
PRIMARYBPAGAKAI
Research & Science Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
NAICS code3 codes
  • Grantmaking Foundations813211
  • Grantmaking and Giving Services81321
  • Voluntary Health Organizations813212
Product category
Research Grant Funding
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Donations and Philanthropic Funding
TypeGrants Donations
Description

Impetus Grants operates as a nonprofit organization funded entirely by donations from individual philanthropists and foundations. Major patrons include Juan Benet, Robert Rosenkranz, Hevolution Foundation, Vitalik Buterin, James Fickel, Fred Ehrsam, Michael Antonov, Jed McCaleb, Karl Pfleger, Molly Mackinlay, and Feruell. The organization received a $10 million commitment from Hevolution Foundation and Rosenkranz Foundation in 2023. Donations are used to provide grants of up to $500k to researchers in the longevity field.

norn.group
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Operations, Personnel, Marketing or Sales, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Impetus Grants is a 501(c)(3) nonprofit grant-making program that funds ambitious, high-risk longevity and aging-biology science by providing scientists with up to $500,000 per project, with funding decisions returned within three weeks. The program operates under Norn Group Inc., has deployed $34M+ across 145 projects, and runs focused thematic grant rounds (e.g., AI-Enabling Datasets) on top of its open application pipeline.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 145 projects funded across three rounds with $34M+ deployed
+4 more records
Product overview1 text field

Impetus Grants is a nonprofit grant program designed to fund ambitious longevity science that would not happen otherwise. It operates as a focused funding mechanism providing up to $500k within 3 weeks for scientists working on the most important problems in aging biology. The core Impetus Grants program is supplemented by focused grant rounds like the AI-Enabling Datasets initiative. Research programs span senolytic CAR-T therapy, foundations of aging cellular atlases, rapamycin clinical trials, and aging biomarker validation. To date, $34M+ has been deployed across 145 projects with approximately 1% organizational overhead.

Product and service2 records
1Impetus Grants Core Program
CategoryNonprofit Grantmaking
Description

Core grant-making program providing up to $500,000 in non-dilutive funding to individual scientists working on ambitious, high-risk longevity and aging-biology research projects, with a 3-week decision turnaround. Intended for researchers in academic and independent settings.

2AI-Enabling Datasets Focused Round
CategoryNonprofit Grantmaking
Description

Thematic focused round of grants dedicated to AI-Enabling Datasets and tooling for longevity research, with a $15M fundraising target. Aimed at AI/ML researchers and longevity scientists building datasets that support aging-biology research.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-07-24
Description

Impetus Grants' AI-Enabling Datasets round is designed to generate high-quality datasets for the longevity field to leverage AI for medical breakthroughs. The round combines reviewers in biology and AI, and requires that resulting data is open-source and formatted for ingestion by major AI model architectures.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Methuselah Foundation
TypeDirect peer
Description

Philanthropic organization backing longevity research and prizes (e.g., Mprize), comparable as a donor-funded engine seeding ambitious longevity science.

TypeDirect peer
Description

Long-standing nonprofit funding biomedical aging research through grant programs — comparable mission and grantmaking mechanism, with a more established but slower-moving operating model.

TypeDirect peer
Description

A major philanthropic foundation funding aging and longevity research with billion-dollar-scale commitments, including a $10M commitment to Impetus itself. Directly comparable as a science-focused grantmaker in the same aging-biology space.

TypeBroad incumbent
Description

Alphabet-backed longevity research organization with substantially greater resources, pursuing similar biology-of-aging questions though via internal R&D rather than external grantmaking.

TypeDirect peer
Description

Nonprofit that funds and conducts research into the biology of aging and rejuvenation, operating in the same high-risk, translational longevity niche as Impetus Grants.

TypeBroad incumbent
Description

Well-capitalized biotech focused on cellular rejuvenation, operating in the same longevity biology domain as the researchers Impetus funds, but as a company rather than a grantmaker.

TypeDirect peer
Description

Decentralized autonomous organization pooling crypto-holder capital to fund longevity research — close overlap with Impetus's crypto-major-patron donor base and patient-capital-for-longevity thesis.

TypeEmerging player
Description

Independent research institute focused on aging biology; comparable in scientific focus but primarily operates its own labs rather than funding external researchers.

TypeDirect peer
Description

Crypto-aligned nonprofit funding longevity research and access, with a similar donor base philosophy (open, patient capital for high-impact longevity science) as Impetus.

10NIH National Institute on Aging (NIA)
TypeBroad incumbent
Description

The dominant federal funder of aging research, explicitly referenced by Impetus as the traditional mechanism their program complements — directly comparable as an aging-research grantmaking entity.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Impetus Grants

Research Grant Fundingimpetusgrants.org

Impetus Grants is a 501(c)(3) nonprofit program under Norn Group that provides up to $500,000 within 3 weeks to scientists pursuing high-risk, high-reward research in aging biology and longevity science.

What Impetus Grants does

Impetus Grants is a 501(c)(3) nonprofit grant-making program operated under Norn Group Inc., founded in 2021 and based in San Francisco. It deploys philanthropic donations as research grants of up to $500,000 per project to academic and independent scientists working on high-risk, high-reward questions in aging biology and longevity science. The organization positions itself as filling the gap between government funders (which it characterizes as too slow and risk-averse for speculative ideas) and venture-backed company formation (which it characterizes as too early-stage for some avenues of investigation), with a stated 3-week application-to-decision turnaround and approximately 1% overhead.

Its core offering is a recurring grant cycle, currently anchored by three completed rounds (145 projects, $34M+ cumulatively deployed, 237+ acknowledging publications including in Science, Cell, and Nature) plus an active fourth round, the AI-Enabling Datasets focused initiative, which funds open-source, AI-ready datasets covering organ-level and longitudinal measurements. Funded research areas span senolytic CAR-T cell therapy, single-cell aging atlases, rapamycin clinical trials (ERAP, VIBRANT), and aging biomarker validation. Pricing to recipients is effectively a standardized grant award; the organization earns no revenue in the commercial sense and is funded entirely by donations from named philanthropists and foundations, including a 2023 $10M joint commitment from Hevolution Foundation and Rosenkranz Foundation and a $15M AI-Enabling Datasets round with anchor matching from Robert Rosenkranz.

Impetus Grants firmographics

Firmographics
Name
Impetus Grants
Legal name
Norn Group Inc.
Website
https://impetusgrants.org
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
Impetus Grants is a 501(c)(3) nonprofit program under Norn Group that provides up to $500,000 within 3 weeks to scientists pursuing high-risk, high-reward research in aging biology and longevity science.
Ownership category
akta.pro rank

Impetus Grants industry classification

Industry
Product category
Research Grant Funding
NAICS
Grantmaking Foundations (813211), Grantmaking and Giving Services (81321), Voluntary Health Organizations (813212)
akta.pro industry
PRIMARYBPAGAKAI
Research & Science Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking

Keywords

  • Longevity research funding
  • Aging biology grants
  • Scientific research grants
  • Healthspan research
  • Nonprofit grantmaking

Where Impetus Grants is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Impetus Grants business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Operations, Personnel, Marketing or Sales, Others

Revenue model

  1. Donations and Philanthropic Funding: Impetus Grants operates as a nonprofit organization funded entirely by donations from individual philanthropists and foundations. Major patrons include Juan Benet, Robert Rosenkranz, Hevolution Foundation, Vitalik Buterin, James Fickel, Fred Ehrsam, Michael Antonov, Jed McCaleb, Karl Pfleger, Molly Mackinlay, and Feruell. The organization received a $10 million commitment from Hevolution Foundation and Rosenkranz Foundation in 2023. Donations are used to provide grants of up to $500k to researchers in the longevity field.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Impetus Grants product offering

Product offering

Core offering

Impetus Grants is a 501(c)(3) nonprofit grant-making program that funds ambitious, high-risk longevity and aging-biology science by providing scientists with up to $500,000 per project, with funding decisions returned within three weeks. The program operates under Norn Group Inc., has deployed $34M+ across 145 projects, and runs focused thematic grant rounds (e.g., AI-Enabling Datasets) on top of its open application pipeline.

Product overview

Impetus Grants is a nonprofit grant program designed to fund ambitious longevity science that would not happen otherwise. It operates as a focused funding mechanism providing up to $500k within 3 weeks for scientists working on the most important problems in aging biology. The core Impetus Grants program is supplemented by focused grant rounds like the AI-Enabling Datasets initiative. Research programs span senolytic CAR-T therapy, foundations of aging cellular atlases, rapamycin clinical trials, and aging biomarker validation. To date, $34M+ has been deployed across 145 projects with approximately 1% organizational overhead.

Differentiator

Problem solved

Functional benefit

Products and services

  • Impetus Grants Core Program Core grant-making program providing up to $500,000 in non-dilutive funding to individual scientists working on ambitious, high-risk longevity and aging-biology research projects, with a 3-week decision turnaround. Intended for researchers in academic and independent settings.
  • AI-Enabling Datasets Focused Round Thematic focused round of grants dedicated to AI-Enabling Datasets and tooling for longevity research, with a $15M fundraising target. Aimed at AI/ML researchers and longevity scientists building datasets that support aging-biology research.

Quantifiable outcome

  • 145 projects funded across three rounds with $34M+ deployed
  • +4 more outcomes

Companies that use Impetus Grants

Customer profile

Segments1 record

Ideal customer profiles2 records

Impetus Grants technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Impetus Grants partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • AI/ML Research CommunitycoreStrategic or Co-development Partner · 24 July 2023Impetus Grants' AI-Enabling Datasets round is designed to generate high-quality datasets for the longevity field to leverage AI for medical breakthroughs. The round combines reviewers in biology and AI, and requires that resulting data is open-source and formatted for ingestion by major AI model architectures.

Scale indicators9 records

Recent moves4 records

Expansion highlights4 records

Impetus Grants competitors and assessment

Company assessment

Direct peers

  • Methuselah Foundation: Philanthropic organization backing longevity research and prizes (e.g., Mprize), comparable as a donor-funded engine seeding ambitious longevity science.
  • American Federation for Aging Research (AFAR): Long-standing nonprofit funding biomedical aging research through grant programs — comparable mission and grantmaking mechanism, with a more established but slower-moving operating model.
  • Hevolution Foundation: A major philanthropic foundation funding aging and longevity research with billion-dollar-scale commitments, including a $10M commitment to Impetus itself. Directly comparable as a science-focused grantmaker in the same aging-biology space.
  • SENS Research Foundation: Nonprofit that funds and conducts research into the biology of aging and rejuvenation, operating in the same high-risk, translational longevity niche as Impetus Grants.
  • VitaDAO: Decentralized autonomous organization pooling crypto-holder capital to fund longevity research — close overlap with Impetus's crypto-major-patron donor base and patient-capital-for-longevity thesis.
  • Longevity Science Foundation: Crypto-aligned nonprofit funding longevity research and access, with a similar donor base philosophy (open, patient capital for high-impact longevity science) as Impetus.

Broad incumbents

  • Calico Labs: Alphabet-backed longevity research organization with substantially greater resources, pursuing similar biology-of-aging questions though via internal R&D rather than external grantmaking.
  • Altos Labs: Well-capitalized biotech focused on cellular rejuvenation, operating in the same longevity biology domain as the researchers Impetus funds, but as a company rather than a grantmaker.
  • NIH National Institute on Aging (NIA): The dominant federal funder of aging research, explicitly referenced by Impetus as the traditional mechanism their program complements — directly comparable as an aging-research grantmaking entity.

Emerging players

  • Buck Institute for Research on Aging: Independent research institute focused on aging biology; comparable in scientific focus but primarily operates its own labs rather than funding external researchers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Impetus Grants social profiles

Digital presence

Impetus Grants financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Impetus Grants leadership team

Management profile

Number of profiles

Impetus Grants funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Impetus Grants M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Impetus Grants

What does Impetus Grants do?

Impetus Grants is a 501(c)(3) nonprofit grant-making program that funds ambitious, high-risk longevity and aging-biology science by providing scientists with up to $500,000 per project, with funding decisions returned within three weeks. The program operates under Norn Group Inc., has deployed $34M+ across 145 projects, and runs focused thematic grant rounds (e.g., AI-Enabling Datasets) on top of its open application pipeline.

Is Impetus Grants a public or private company?

Impetus Grants is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Impetus Grants founded?

Impetus Grants was founded in 2021. It employs 1 to 10 people.

Where is Impetus Grants based?

Impetus Grants is headquartered in San Francisco, United States, in the North America region.

How does Impetus Grants make money?

One revenue line is on record: donations and Philanthropic Funding.

Who are Impetus Grants's main competitors?

Direct peers on record are Methuselah Foundation, American Federation for Aging Research (AFAR), Hevolution Foundation, SENS Research Foundation, VitaDAO and Longevity Science Foundation. Broad incumbents are Calico Labs, Altos Labs and NIH National Institute on Aging (NIA). Buck Institute for Research on Aging is listed as an emerging player.

Does Impetus Grants have an API?

No public API is recorded for Impetus Grants.

What industry is Impetus Grants in?

Impetus Grants's product category is Research Grant Funding. Its primary akta.pro industry code is BPAGAKAI, Research & Science Grantmaking Foundations, with a secondary code of BPAGAKAL, Health & Medical Research Grantmaking Foundations. Its NAICS code is 813211.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals